ROS-Generating Amine-Functionalized Magnetic Nanoparticles Coupled with Carboxymethyl Chitosan for pH-Responsive Release of Doxorubicin

Sreekanth Reddy Obireddy,Wing-Fu Lai

DOI: https://doi.org/10.2147/IJN.S338897

IF: 7.033

2022-02-08

International Journal of Nanomedicine

Abstract:Sreekanth Reddy Obireddy, 1, 2 Wing-Fu Lai 2 1 Department of Chemistry, Sri Krishnadevaraya University, Anantapur, 515003, India; 2 Ciechanover Institute of Precision and Regenerative Medicine, The Chinese University of Hong Kong (Shenzhen), Shenzhen, 518172, People's Republic of China Correspondence: Wing-Fu Lai Ciechanover Institute of Precision and Regenerative Medicine, The Chinese University of Hong Kong (Shenzhen), Shenzhen, 518172, People's Republic of China , Email Purpose: Magnetic nanoparticles have been used in diverse pharmaceutical applications because they can potentially be used to target specific sites. In the present work, a new type of nanocomposites is designed as a carrier of controlled bioactive agent delivery. Methods: Amine-functionalized magnetic nanoparticles (amine-MNPs) are coupled with carboxymethyl chitosan (CMC) to generate the nanocomposites, namely MNPs-CMC, which can be further loaded with doxorubicin (DOX) to produce MNPs-CMC-DOX. The generated nanocomposites are characterized by using various techniques (including FTIR, 1 H-NMR, DSC, TGA, SEM, TEM and XRD). In vitro drug release studies are conducted in PBS with different pH values (1.2 and 6.8) at different temperatures (25°C and 37°C). The toxicity of the nanocomposites is tested in MCF-7 and 3T3 cells. The ROS-generating capacity of the nanocomposites is determined in treated cells using 2',7'-dichlorodihydrofluorescein diacetate. Results: The structures of MNPs, CMC, and nanocomposites are confirmed by FTIR, XRD, and 1 H-NMR data reveals the formation of CMC from chitosan (CS). The size of MNPs is estimated by TEM to be around 25 nm. After conjugation with CMC, the size of the nanocomposites increases to 46– 57 nm. Based on the release profiles of MNPs-CMC-DOX, our nanocomposites are pH-responsive. In addition, our nanocomposites show reactive oxygen species (ROS)-generating capacity and cell type-dependent toxicity. Conclusion: Our nanocomposites show high potential for use in bioactive agent delivery. Along with their ROS-generating capacity, they warrant further development as pH-responsive carriers for therapeutic applications. Keywords: nanocomposites, drug delivery, controlled release, biocompatibility Graphical Metal nanoparticles show physical and chemical properties that are different from their corresponding bulk materials. 1,2 For this, metal nanoparticles show high toxicity even though the same metal exhibits inertness in its bulk form. 3,4 An earlier study has found that gold nanoparticles (with the diameter of around 50 nm) can result in a range of toxicological features upon administration in vivo. 5 A similar observation has also been reported by Park et al, 6 who have noted that intratracheal and intravenous administration of platinum nanoparticles in vivo can elicit inflammation, causing an increase in cytokine generation and in the immunoglobulin E (IgE) concentration. When the size of the nanoparticles is small enough to enter the nucleus, the genetic material of the cell may even be affected. 7 More recently, Alarifi et al reported that nickel nanoparticles cause oxidative stress in cells by stimulating the formation of reactive oxygen species. 8 An increase in the level of membrane lipid peroxidation (LPO) and the amount of ROS, and a decrease in intracellular glutathione concentrations, are observed in vitro after exposure to metal nanoparticles. 9 This sheds light on the possibility of using nanoparticles as ROS-generating materials for therapeutic purposes. This possibility has been corroborated by the case of Fe 3 O 4 (magnetite) and γ-Fe 2 O 3 (maghemite) nanoparticles, which have recently been extensively exploited for biomedical applications, including magnetic resonance imaging (MRI) and hyperthermia. 10–15 For the latter, malignant tumours are more sensitive to heat than normal tissues at around 41–47°C. Once magnetic metal nanoparticles enter cancer cells and are subjected to an alternate magnetic field, they absorb energy, with the relaxation effect producing a heating effect to cause the death of the cancer cells. 16–18 In recent years, researchers have attempted to combine magnetic nanoparticles with a variety of anticancer agents [such as 5-fluorouracil, 19 paclitaxel, 20 and doxorubicin (DOX) 21 ] for cancer treatment. Apart from metal nanoparticles, natural biodegradable polymers are advancing the research front in bioactive agent delivery. 22–25 For instance, chitin and its derivatives have been employed to administer drugs or nutrition -Abstract Truncated-